Get started
Medipharm Labs CorporationMedipharm Labs CorporationMedipharm Labs Corporation

Medipharm Labs Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MEDIF trade ideas

From 5.50 to under 0.50 stock, would you buy ?Read latest news here , here Think about stock investment like America got Talent show. If a stock has good potential but lack coverage by analysts, institutional buyers, media coverage, etc, it would take some time for investors to take notice. The show or the analysts coverage, etc are the platform that sells the company, promote its USP to the millions of investors out there who have nothing but choices of companies to invest in. Thus, someone who is able to analyse it and package it neatly in a compelling manner would help raise its profile. Not for MJ , at least for now. Chart wise, though it has broken out of the descending wedge pattern formed in May 2019, clearly the buying power is weak and I forsee more sideway movement. The March 20 revenue data release might be a trigger or we need some positive news to drive up this stock. I will revisit this chart again when it breaks out of 0.85 resistance level, so this goes to my watchlist for now.
OTC:MEDIF
by dchua1969
3
MEDIPHARM LONG SETUPLooking at a potential low risk high reward play here. Although i pointed out the previous bull run above, I don't expect anything close to that happening at all. We are currently under a death cross and earnings are coming up, note it usually dumps at earnings after all-time-highs. This is a company I am looking at long-term though so I will buy small at this level only because of the number of opportunities in the market right now, but will essentially look out for lower prices and possible bullish divergences in which case I would up my bet. Any rally here I would anticipate a breakout and continuation possibly to that .618 fib level which seems to be respected a lot throughout this bear market, and just so happens that the 50MA is lining up with it as well. Not investment advice, just my opinion on the market. Safe trading, cheers.
TSX:LABS
by thiluxan_s
2
LABS Earnings Next WeekWhat's in store for Q4 earnings? I have no idea. I do know that I like LABS a lot. As with my other favourites, solid fundamentals and high growth potential. Fell right through my target - I ended up buying twice - and then bounced nicely. I am looking for a short term, sustained bounce towards $3.35 level, then gather some strength before moving higher again. If the broader markets continue to recover, I see LABS as a winner. If broader markets go for another round of selling, I believe my investment is safe here. A growth stock with some value.
TSX:LABS
by Barkworth
LABS Regression Trend| Higher Low| Key ResistanceHello Traders! Today’s chart update will be on LABS – Canadian MJ – which has been trading in a clear regression trend, close to testing upper resistance, is a break imminent? Points to consider, - Clear bear trend - Support provided by 50 MA - Regression trend resistance to break - Stochastics in lower regions - RSI respecting trend - Volume below average LABS bear trend has been putting in consecutive lower highs, with a first higher low coming to fruition, a trend change may be probable. Support is currently being provided by the 50 MA, all averages will eventually need to hold LABS when testing key resistance. The Regression trend resistance is a staunched area that LABS must close above to register for a probable trend change. Stochastics are in the lower regions, can stay trading here for an extended period of time, however lots of stored momentum to the upside. The RSI is respecting its trend line, currently neutral, not at extreme ends. LABS volume needs to stay above average for continued follow though when breaking levels. Overall, in my opinion, a break and close above key structural resistance will confirm a trend change. LABS, does need to increase volume otherwise a rejection at currently trading level will become more probable. What are your thoughts? Please leave a like and comment, And remember, “Trading effectively is about assessing probabilities, not certainties.” ― Yvan Byeajee
TSX:LABSLong
by AzizKhanZamani
$MEDIF Medipharm Labd jumps on NAsdaq prospectMediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
OTC:MEDIF
by DEXWireNews
1